Celldex Therapeutics, Inc. (CLDX) SEC Filings — 2024

Filings

• Celldex Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Celldex Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Celldex Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• Celldex Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Celldex Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• Celldex Therapeutics Q3 2024 Financial Update — 10-Q · Nov 6, 2024
• Celldex Therapeutics Files 8-K on Financials — 8-K · Nov 6, 2024
• Celldex Therapeutics Q2 2024 Update: Cash Dips, Operations Continue — 10-Q · Aug 8, 2024
• Celldex Therapeutics Files 8-K on Financials — 8-K · Aug 8, 2024
• Bristol Myers Squibb to Acquire Celldex Therapeutics for $5.1B — 8-K · Jun 14, 2024
• Celldex Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 6, 2024
• Celldex Therapeutics Files 8-K on Financials — 8-K · May 6, 2024
• Celldex Therapeutics Announces 2024 Annual Meeting of Stockholders on June 13 — DEF 14A · Apr 25, 2024
• Celldex Therapeutics Enters Material Definitive Agreement — 8-K · Mar 1, 2024
• Celldex Therapeutics Files 2023 10-K — 10-K · Feb 26, 2024
• Celldex Therapeutics Updates Financial Condition in 8-K Filing — 8-K · Feb 26, 2024
• Celldex Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Celldex Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Celldex Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Vanguard Discloses 7.0% Stake in Celldex Therapeutics — SC 13G/A · Feb 13, 2024
• Polar Capital Holdings Plc Reports 5.0% Stake in Celldex Therapeutics — SC 13G · Feb 13, 2024
• FMR LLC & Abigail Johnson Maintain 12.89% Stake in Celldex (CLDX) — SC 13G/A · Feb 9, 2024
• Wellington Management Discloses 6.02% Stake in Celldex Therapeutics — SC 13G/A · Feb 8, 2024
• BlackRock Amends Celldex Therapeutics Stake, Holds Significant Position — SC 13G/A · Jan 26, 2024